resveratrol has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, M; Ishida, S; Korthuis, RJ; Sakata, T; Shigematsu, S; Takahashi, N; Yoshimatsu, H | 1 |
| Balestrieri, C; Balestrieri, ML; Felice, F; Montoro, P; Oleszek, W; Piacente, S; Pizza, C; Visciano, V | 1 |
| Antonopoulou, S; Apostolakis, C; Fragopoulou, E; Karantonis, HC; Nomikos, T; Panayotou, G; Pliakis, E; Samiotaki, M | 1 |
| Antonopoulou, S; Asimakopoulos, D; Demopoulos, CA; Fragopoulou, E; Xanthopoulou, MN | 1 |
| Antonopoulou, S; Fragopoulou, E; Kostakis, IK; Stamatakis, GM; Vlachogianni, IC | 1 |
| Chen, B; Chen, K; Gong, H; Qi, R; Sun, J; Zhang, M; Zhao, X; Zhao, Y | 1 |
6 other study(ies) available for resveratrol and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants.
Topics: Animals; Antioxidants; Cell Adhesion; Flavonoids; Free Radicals; Hypoxanthine; Inflammation; Leukocytes; Leukotriene B4; Male; Oxidants; Phenols; Platelet Activating Factor; Polyphenols; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Resveratrol; Stilbenes; Superoxide Dismutase; Superoxides; Time Factors; Xanthine Oxidase | 2003 |
Relative effects of phenolic constituents from Yucca schidigera Roezl. bark on Kaposi's sarcoma cell proliferation, migration, and PAF synthesis.
Topics: Antineoplastic Agents; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Plant Bark; Plant Extracts; Platelet Activating Factor; Resveratrol; Sarcoma, Kaposi; Spiro Compounds; Stilbenes; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Yucca | 2006 |
Biological activity of acetylated phenolic compounds.
Topics: Acetylation; Animals; Chromatography, High Pressure Liquid; Phenylethyl Alcohol; Platelet Activating Factor; Platelet Aggregation; Rabbits; Resveratrol; Spectrometry, Mass, Electrospray Ionization; Stilbenes | 2007 |
Effect of Robola and Cabernet Sauvignon extracts on platelet activating factor enzymes activity on U937 cells.
Topics: Atherosclerosis; Humans; Platelet Activating Factor; Resveratrol; Stilbenes; U937 Cells; Wine | 2014 |
Platelet Activating Factor (PAF) biosynthesis is inhibited by phenolic compounds in U-937 cells under inflammatory conditions.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acetylation; Acetyltransferases; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cell Line; Diacylglycerol Cholinephosphotransferase; Down-Regulation; Enzyme Activation; Enzyme Inhibitors; Humans; Interleukin-1beta; Monocytes; Osmolar Concentration; Phenylethyl Alcohol; Platelet Activating Factor; Recombinant Proteins; Resveratrol; Stilbenes | 2015 |
Suppression of TLR4 activation by resveratrol is associated with STAT3 and Akt inhibition in oxidized low-density lipoprotein-activated platelets.
Topics: Blood Platelets; Gene Expression Regulation; Humans; Lipoproteins, LDL; Phosphorylation; Platelet Activating Factor; Platelet Activation; Platelet Adhesiveness; Proto-Oncogene Proteins c-akt; Resveratrol; STAT3 Transcription Factor; Toll-Like Receptor 4; Transcription Factor RelA | 2018 |